Effectiveness of Oral and Subcutaneous Semaglutide Statistically significant improvements from baseline were seen for both formulations in HbA 1c (19.3 18.4 mmol/mol [ 1.77 1.68%] and 20.8 15.4 mmol/mol [ 1.90 1.41%] for oral and subcutaneous respectively), body weight ( 9.0 10.2 kg and 7.2 9.4 kg), BMI ( 3.3 3.8 kg/m 2 and 2.5 3.3 kg/m 2 ), and total cholesterol ( 0.24 0.49 mmol/l and 0.38 0.92 mmol/l), (Fig
GHK-Cu is also thought to be a powerful antioxidant, which may support wound healing, reduce inflammation, and enhance skin regeneration
Price TO, Ercal N, Nakaoke R, Banks WA
A TD Cowen analyst said to Reuters that the current status quo lets compounders create copycat drugs if they make minor tweaks they claim benefit specific patient groups, leaving the door pretty wide open. All of this lands as Novo already faces pricing and patent pressure
The transformation in skin quality from where I started is something I did not expect from a peptide